Paediatric Respiratory Pathogen Report
Week 14, 9th April 2017
Week Ending
RSV
INF-A
INF-B
PIV 1-3
hMPV
hAdV
RV
B. pertussis
M. pneumoniae
9/04/2017
3
0
0
2
0
4
8
0
1
2/04/2017
14
1
1
6
3
5
11
0
0
26/03/2017
9
1
0
2
6
5
2
1
0
19/03/2017
11
2
0
2
3
6
5
1
1
12/03/2017
5
1
0
4
1
3
9
1
1
5/03/2017
10
0
0
2
2
9
10
0
0
26/02/2017
2
2
1
2
0
0
5
0
0
April total
3
0
0
2
0
4
8
0
1
March total
49
5
1
16
15
28
37
3
2
Table 1: The number of hospitalised and ED paediatric patientsi with respiratory
pathogens identified at PathWest PMH/QE2.
Respiratory Pathogen
No. Detected 2017
to 09/04/2017
No. Detected 2016
to 09/04/2016
No. Detected 2016
Total
Respiratory syncytial virus (RSV)
71
30
805
Influenza A (INF-A)
11
18
197
Influenza B (INF-B)
2
4
87
Parainfluenza virus (PIV) 1-3
32
56
297
Human metapneumovirus (hMPV)
31
10
247
Adenovirus (hAdV)
64
63
287
Rhinovirus (RV)*
92
69
435
Bordetella pertussis
14
19
32
Mycoplasma pneumoniae
6
6
20
Table 2: Total numbers of hospitalised and ED paediatric patients with respiratory
pathogens for 2017 identified at PathWest PMH/QE2, compared to 2016. *RV figures are
from 21/2/2016 onwards.
Figure 1: RSV percentage positive of hospitalised and ED paediatric patients, for which a
respiratory sample was collected and referred to PathWest PMH/QE2 for 2015-2017
Figure 2: Influenza percentage positive of hospitalised and ED paediatric patients, for which a
respiratory sample was collected and referred to PathWest PMH/QE2 for 2015-2017
Data supplied by:
Surveillance Unit
PathWest Laboratory Medicine WA
QE2 Medical Centre
Nedlands WA 6009
i
Data is for all patients under the age of 16 admitted to hospital or presenting to an ED for all public/private hospitals
in Western Australia, for which a respiratory sample was collected and referred to PathWest PMH/QE2.